Mon, March 25, 2013
Fri, March 22, 2013
Thu, March 21, 2013
Wed, March 20, 2013
Tue, March 19, 2013
Mon, March 18, 2013
Fri, March 15, 2013

Andrew Peters Maintained (BMRN) at Hold with Increased Target to $59 on, Mar 20th, 2013

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-59-on-mar-20th-2013.html
  Print publication without navigation Published in Stocks and Investing on by
          🞛 This publication is a summary or evaluation of another publication

Andrew Peters of Deutsche Bank, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Increased Target from $45 to $59 on, Mar 20th, 2013.

Andrew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $71 on, Tuesday, February 12th, 2013
  • Martin Auster of "UBS" Maintained at Strong Buy with Increased Target to $67 on, Friday, February 1st, 2013